Plasma Proteins
Plasma Proteins
Plasma and serum, electrophoresis, albumin, globulins, acute-phase proteins, blood coagulation and fibrinolysis.
1 Plasma and Serum
Plasma constitutes about 55–60% of blood.
When blood containing an anticoagulant such as heparin, potassium oxalate or citrate is centrifuged, the plasma separates as the supernatant while the cells settle at the bottom.
The packed cell volume or hematocrit is about 45%.
Plasma vs Serum
Serum is the liquid that separates after blood has clotted.
The main difference is the presence of fibrinogen and other clotting factors in plasma, whereas serum does not contain fibrinogen and other clotting factors.
Plasma = physiological fluid prepared in the laboratory.
Serum = fluid obtained after blood clotting.
Functions of Blood
Blood performs several important functions, including:
- Respiration
- Excretion
- Acid-base maintenance
- Water balance
- Transport of metabolites
- Transport of hormones
- Transport of drugs
- Body defense
- Coagulation
2 Separation of Plasma Proteins
Plasma is a complex mixture of proteins, and different techniques can be used to separate them.
Major Groups
By salting-out methods, plasma proteins can be separated into:
- Albumin
- Globulins
- Fibrinogen
Electrophoresis
Electrophoresis is the commonly used analytical technique for separating plasma or serum proteins.
It separates serum proteins into five major fractions:
The concentration of each fraction can be estimated using a densitometer.
Abnormal Electrophoretic Patterns
- Multiple myeloma: a sharp and distinct M-band appears in the γ-globulin region.
- Acute infections: α1 and α2 globulins increase.
- Nephrotic syndrome: albumin decreases with a sharp increase in α2-globulin.
- Primary immune deficiency: γ-globulin band is diminished.
- α1-antitrypsin deficiency: α1-globulin band is diminished.
Albumin/Globulin Ratio
Plasma albumin concentration is approximately 3.5–5.0 g/dL, while total globulin concentration is about 2.5–3.5 g/dL.
The normal albumin/globulin ratio is approximately 1.2–1.5 : 1.
The ratio may decrease because of decreased albumin or increased globulins.
3 Albumin
Its concentration is approximately 3.5–5.0 g/dL.
Human albumin has a molecular weight of about 69,000 Da and consists of a single polypeptide chain containing 585 amino acids with 17 disulfide bonds.
Synthesis of Albumin
Albumin is synthesized exclusively by the liver.
Therefore, measurement of serum albumin is commonly used in assessing liver function.
The liver produces approximately 12 g of albumin per day, representing about 25% of total hepatic protein synthesis.
Albumin has a half-life of about 20 days.
Functions of Albumin
1. Osmotic Function
Because albumin is present in high concentration and has a relatively low molecular weight, it contributes about 75–80% of total plasma osmotic pressure.
It therefore helps maintain blood volume and body-fluid distribution.
2. Transport Function
Albumin binds several biologically important substances and transports them through the circulation.
- Free fatty acids
- Bilirubin
- Steroid hormones
- Calcium
- Copper
3. Nutritive Function
Albumin serves as a source of amino acids for tissue protein synthesis, particularly during nutritional deprivation.
4. Buffering Function
Albumin has the maximum buffering capacity among plasma proteins, although its contribution is not as significant as the bicarbonate buffer system.
Clinical Significance of Albumin
Reduction of plasma albumin decreases plasma osmotic pressure. This promotes movement of water into the interstitial compartment and may produce edema.
Albumin may also be lost in urine in nephrotic syndrome and certain inflammatory conditions of the urinary tract.
Microalbuminuria is clinically important in predicting future risk of renal disease.
Albumin can also be therapeutically useful in the treatment of burns and hemorrhage.
4 Globulins
In general, globulins are larger in size than albumin.
α1-Antitrypsin
α1-Antitrypsin, also called α1-antiproteinase, is a glycoprotein present in the α1-globulin fraction.
It is a serine protease inhibitor and inhibits enzymes such as trypsin, elastase and other proteases.
Smoking causes oxidation of an amino acid in α1-antitrypsin, reducing its ability to bind and inactivate proteases. Emphysema is more commonly associated with heavy smoking, and the condition becomes worse in people with α1-antitrypsin deficiency.
α2-Macroglobulin
α2-Macroglobulin is a protease inhibitor.
Its plasma concentration is increased in nephrotic syndrome, partly because of the loss of smaller proteins in urine.
Haptoglobin
Haptoglobin is a glycoprotein and an acute-phase protein.
It binds free hemoglobin released into plasma during hemolysis.
Plasma haptoglobin decreases in hemolytic anemia because free hemoglobin increases and more haptoglobin is consumed in forming the hemoglobin–haptoglobin complex.
Ceruloplasmin
Ceruloplasmin is a blue-coloured copper-containing α2-globulin.
It binds most of the copper in plasma and has antioxidant activity.
It is associated with Wilson’s disease, which involves abnormal copper metabolism.
Transferrin
Transferrin is a glycoprotein responsible for transporting iron in the circulation.
Transferrin levels increase in iron-deficiency anemia and decrease in nephrotic syndrome.
5 Other Important Plasma Proteins
Prealbumin
Transports thyroxine to some extent.
Retinol-Binding Protein
Transports vitamin A.
Thyroxine-Binding Globulin
Transports thyroid hormones.
Transcortin
Transports steroid hormones such as cortisol and corticosterone.
Hemopexin
Transports heme.
Plasminogen
Forms plasmin and participates in fibrinolysis.
Fibrinogen
Participates in blood coagulation and is converted to fibrin during clot formation.
Immunoglobulins
γ-globulins include immunoglobulins and have antibody functions.
6 Acute-Phase Proteins
Their changes form part of the body’s immediate response to external threats.
Important Acute-Phase Proteins
C-Reactive Protein (CRP)
CRP is a major acute-phase protein produced by the liver.
It increases rapidly during inflammation and is used as a nonspecific marker of infection, inflammation and tissue injury.
High-sensitivity CRP is useful in assessing the risk of coronary heart disease.
Haptoglobin
Binds free hemoglobin released from red blood cells.
It increases in acute and chronic inflammatory conditions and decreases during hemolysis.
α1-Antitrypsin
A protease inhibitor that protects tissues from enzyme damage.
It is associated with emphysema and liver disease when deficient.
Ferritin
Major iron-storage protein.
Its level increases in infection, inflammation and chronic disease and decreases in iron-deficiency anemia.
Ceruloplasmin
Copper-binding protein with antioxidant properties.
α2-Macroglobulin
Protease inhibitor that increases during acute and chronic inflammation and in nephrotic syndrome.
Transferrin
Iron-binding transport protein.
It decreases during inflammation and chronic disease.
7 Blood Clotting
Blood coagulation involves a series of reactions involving numerous different substances, many of which are glycoproteins synthesized by the liver.
Two Pathways
Extrinsic Pathway
This is the rapid pathway initiated by tissue injury.
It involves factors that are not normally present in circulating blood.
Intrinsic Pathway
This pathway involves factors already present in blood and is activated through contact with a wound surface.
Both pathways ultimately converge into the common pathway and lead to formation of factor Xa.
Final Common Pathway
Important Clotting Factors
Conversion of Fibrinogen to Fibrin
Fibrinogen is a soluble glycoprotein present in plasma.
Thrombin acts on fibrinogen and releases fibrinopeptides, producing fibrin monomers.
Fibrin monomers join together to form a clot. The clot is further stabilized by covalent cross-linking between fibrin molecules.
Conversion of Prothrombin to Thrombin
Prothrombin is the inactive zymogen form of thrombin.
Its activation occurs on platelets and requires factors Va and Xa, phospholipids and Ca2+.
Intrinsic Pathway in Brief
Exposure to a wound surface activates factor XII.
Activated factor XII activates factor XI, which activates factor IX. Factor VIIIa participates in the next stage and contributes to activation of factor X.
Extrinsic Pathway in Brief
Tissue factor and factor VIIa participate in activation of factor X.
The tissue factor is described as being present in tissues including lung and brain.
8 Anticoagulants
Calcium-Binding Anticoagulants
Calcium is required for several reactions of blood coagulation.
Substances that bind calcium can therefore act as effective anticoagulants.
- Oxalate
- EDTA
- Citrate
Heparin
Heparin is an anticoagulant used to maintain normal hemostasis.
It is a heteropolysaccharide found in many tissues, including mast cells and the endothelium of blood vessels.
Heparin combines with antithrombin III, which inhibits clotting factors including II, IX, X, XI, XII and kallikrein.
Heparin may be administered to patients during and after surgery to prevent blood clotting.
Protein C
Protein C is another anticoagulant present in blood.
It is activated by thrombin and inactivates clotting factors V and VIII.
Low-Molecular-Weight Heparins
Low-molecular-weight heparins are anticoagulant medications used to prevent blood clots and in the treatment of myocardial infarction, deep-vein thrombosis and pulmonary embolism.
Warfarin
Warfarin is a vitamin K antagonist and may be used as an oral anticoagulant.
It acts by reducing synthesis of certain clotting factors, including factors II, VII, IX and X.
9 Fibrinolysis
Plasmin is mainly responsible for the dissolution of fibrin clots.
Plasminogen is the inactive precursor of plasmin and is synthesized in the kidney.
Activation of Plasminogen
Tissue plasminogen activator and urokinase convert plasminogen into plasmin.
Streptokinase is a therapeutic fibrinolytic agent that activates plasminogen.
It may be administered immediately after symptoms of myocardial infarction, pulmonary embolism and deep-vein thrombosis.
10 Abnormalities of Blood Clotting
Abnormalities associated with blood clotting may result from defects in clotting factors and may be inherited or acquired.
Hemophilia A
Affected individuals have prolonged clotting time and may suffer from internal bleeding, particularly in joints and the gastrointestinal tract.
Hemophilia B
Hemophilia B, also called Christmas disease, results from deficiency of Christmas factor IX.
Its clinical symptoms are almost similar to those of hemophilia A.
Von Willebrand’s Disease
Von Willebrand’s disease is characterized by failure of platelets to aggregate properly and is due to a defect in the platelet adherence factor.
Other Clinical Associations
- α1-Antitrypsin deficiency: associated with emphysema and liver disease.
- Nephrotic syndrome: associated with changes in albumin and α2-globulin fractions and may produce edema.
- Wilson’s disease: associated with abnormal copper metabolism and ceruloplasmin.
- Iron-deficiency anemia: associated with increased transferrin levels.
11 Quick Revision
Key Points to Remember
- Plasma forms about 55–60% of blood and contains blood cells in suspension.
- Serum is obtained after blood clotting and lacks fibrinogen and other clotting factors.
- Total plasma protein concentration is about 6–8 g/dL.
- Electrophoresis separates serum proteins into albumin, α1, α2, β and γ fractions.
- Albumin is the major plasma protein and is synthesized exclusively by the liver.
- Albumin performs important osmotic, transport, nutritive and buffering functions.
- Hypoalbuminemia decreases plasma osmotic pressure and may lead to edema.
- α1-Antitrypsin inhibits proteases and its deficiency is associated with emphysema and liver disease.
- Haptoglobin binds free hemoglobin released during hemolysis.
- Ceruloplasmin transports copper and has antioxidant activity.
- Transferrin transports iron in the circulation.
- Acute-phase proteins change in concentration in response to infection, injury and inflammation.
- CRP is an important marker of inflammation and tissue injury.
- Blood coagulation involves intrinsic and extrinsic pathways that converge into a common pathway.
- Factor Xa participates in the common pathway leading to conversion of prothrombin into thrombin.
- Thrombin converts fibrinogen into fibrin, producing the structural basis of the blood clot.
- Anticoagulants include calcium-binding substances, heparin, low-molecular-weight heparins and warfarin.
- Plasmin is mainly responsible for fibrin clot dissolution during fibrinolysis.
- Hemophilia A results from factor VIII deficiency, while hemophilia B results from factor IX deficiency.
- Von Willebrand’s disease involves defective platelet aggregation/adherence.